Perioperative Fluid Management and Renal Protection in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A Scoping Review. [PDF]
Pasta G +8 more
europepmc +1 more source
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: a comprehensive review. [PDF]
Li Y, Xu X.
europepmc +1 more source
Conversion Therapy for Gastric Cancer with Peritoneal Metastasis
Peritoneal metastasis in gastric cancer has a poor prognosis and is increasing in prevalence. Neoadjuvant chemotherapy is used for advanced tumors; however, surgery is generally not considered for metastatic and unresectable diseases.
Thita Intralawan +9 more
doaj
Logistic regression analysis of risk factors for abdominal adhesion during hyperthermic intraperitoneal chemotherapy for ovarian cancer. [PDF]
Yao J, Chen J.
europepmc +1 more source
Sclerosing Encapsulating Peritonitis Is More Common Following Repeat Hyperthermic Intraperitoneal Chemotherapy. [PDF]
Davydov A +2 more
europepmc +1 more source
Impact of Omission of Hyperthermic Intraperitoneal Chemotherapy for Treatment of Colorectal Peritoneal Metastases. [PDF]
Im K, Yoshinaga S, Leung AM.
europepmc +1 more source
Advances and challenges in the application of prophylactic hyperthermic intraperitoneal chemotherapy for gastric cancer. [PDF]
Liu M, Shen X.
europepmc +1 more source
The impact on sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer treatment. [PDF]
Falla-Zuniga LF +8 more
europepmc +1 more source
Surgical education video: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Ovarian Cancer. [PDF]
Huizar GD +3 more
europepmc +1 more source
Sustained disease control in ovarian carcinosarcoma treated with postoperative hyperthermic intraperitoneal chemotherapy and targeted maintenance: a case report. [PDF]
Xu S +8 more
europepmc +1 more source

